Asterand Biosciences is Biotechnology in United States that focus on cell culture media business. Founded in 2007. They cover business area such as developer, innovative technology, reagent, cellular reprogramme research, a supplier, cellular reprogramme product, tissue-base research, tool, cell research, stem cell reprogramming, mrna reprogramme system, cell culture medium, reprogramme service, stem cell scientist.
2007
( 17 years old in 2024 )
Cell Culture Media
-
4 Hartwell Place
Lexington, MA 02421
United States
Private
developerinnovative technologyreagentcellular reprogramme researcha suppliercellular reprogramme producttissue-base researchtoolcell researchstem cell reprogrammingmrna reprogramme systemcell culture mediumreprogramme servicestem cell scientist
* We use standard office opening hours in near Asterand Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Asterand Biosciences is Biotechnology business from United States that founded in 2007 (17 years old in 2024), Asterand Biosciences business is focusing on Cell Culture Media.
Asterand Biosciences headquarter office and corporate office address is located in 4 Hartwell Place Lexington, MA 02421 United States.
Asterand Biosciences was founded in United States.
In 2024, Asterand Biosciences is currently focus on cell culture media sector.
Above is snippet of Google Trends for "cell culture media" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Asterand Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
